Overall Status

Terminated (2)

Completed (1)

Phase

phase 2 (3)

Sponsor

Academic and Community Cancer Research United (1)

Case Comprehensive Cancer Center (1)

Roswell Park Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (3)

National Comprehensive Cancer Network (1)

Study Documents

Intervention Type

drug (3)

other (3)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stage iiib esophageal adenocarcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adenocarcinoma of the Gastroesophageal Junction, Stage IIB Esophageal Adenocarcinoma, Stage IIIA Esophageal Adenocarcinoma Trial

Terminated

Has Results

Adenocarcinoma of the Gastroesophageal Junction
+4 more

Placebo
Regorafenib

Urbana, Illinois
+9 more

Oct 15, 2018

Stage IB Esophageal Adenocarcinoma, Stage IIA Esophageal Adenocarcinoma, Stage IIB Esophageal Adenocarcinoma Trial in Cleveland

Terminated

Has Results

Stage IB Esophageal Adenocarcinoma
+5 more

Paclitaxel
+7 more

Cleveland, Ohio

Case Comprehensive Cancer Center

Jan 16, 2018

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma, Gastric Adenocarcinoma Trial in Buffalo,

Completed

Has Results

Adenocarcinoma of the Gastroesophageal Junction
+16 more

Laboratory Biomarker Analysis
+2 more

Buffalo, New York
+1 more

Nov 14, 2017